TREM1 and metabolic syndrome: Inflammation leads to HDL reduction and LDL and VLDL production in the cells via impairment in the reverse cholesterol transport system [25]; another possible mechanism is triggering receptor expressed on myeloid cells-1 (TREM-1) induced dyslipidemia and consequently, fat deposition and pro-inflammatory cytokines production [26].